The strength of this association was not attenuated after further adjustment for obesity, diabetes, CHD, past history of HF, LV-ejection fraction, eGFRCKD-EPI and plasma NT-proBNP levels (model 2). This evidence concerns the gene NPPB and obesity due to melanocortin 4 receptor deficiency.